| Delta Regional Med.ctr.hha | |
| 300 South Washington Ave / Po Box 5247, Greenville, Mississippi 38701 | |
| (662) 725-1200 | |
| Name | Delta Regional Med.ctr.hha |
|---|---|
| Location | 300 South Washington Ave / Po Box 5247, Greenville, Mississippi |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 257098 |
| Ownership Type | Government - State/county |
| Service Area Zip Codes | 38701, 38702, 38703, 38704, 38722, 38725, 38730, 38732, 38744, 38748, 38751, 38753, 38756, 38759, 38760, 38780 |
| NPI Number | 1477651362 |
| Organization Name | DELTA HEALTH SYSTEM |
| Doing Business As | DELTA HEALTH-THE MEDICAL CENTER |
| Address | 1693 Fairgrounds Rd, Greenville, MS 38703 |
| Phone Number | 662-725-1200 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.
› Verified 2 days ago
| Quality Rating: |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 98.3 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 79.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 70.7 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.
› Verified 2 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 73.7 | 79.6 |
| How often patients got better at getting in and out of bed | 89.1 | 81.1 |
| How often patients got better at bathing | 75.7 | 82.3 |
| How often patients’ breathing improved | 70.3 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 75.1 | 75 |
| How often home health patients had to be admitted to the hospital | 18.5 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.7 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 100 | 94 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.
› Verified 2 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.
› Verified 2 days ago
The patient survey data of Delta Regional Med.ctr.hha is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 87 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 82 | 78 |
News Archive
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.
At a summit held yesterday in Boston, Attorney General Eric Holder said the nation's crackdown on health care fraud and abuse is paying off, and Health and Human Services Secretary Kathleen Sebelius talked about new approaches that are contributing to such successes. Meanwhile, a new analysis names big pharma as the nation's "biggest defrauder" under the False Claims Act.
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
A Japanese study shows that intraocular pressure increases during robotic-assisted radical prostatectomy with the patient in a steep Trendelenburg position, but this is not associated with an increased risk for postoperative complications or changes in visual function.
› Verified 2 days ago
Delta Regional Med.ctr.hha Location: 300 South Washington Ave / Po Box 5247, Greenville, Mississippi 38701 Ratings: Phone: (662) 725-1200 |